Language

CAS No.151767-02-1 | Montelukast sodium

Name: Montelukast sodium CAS No.151767-02-1 MF:C35H37ClNNaO3S MW:610.18 Purity:98% Package: 10g,25g,50g,100g,250g Worldwide Delivery

Categories：

Pharmaceutical Intermediates

Email：sale06@alfachem.cn

Inquiry

Chat Now

Product introduction

Introduction and application of CAS No. 151767-02-1 | Montelukast sodium

Synonyms:montelucast-d6;

MontelukastSoudiumTablets;

Montelukastsodium,99%;

1-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-Methylethyl)phenyl]propyl]thio]Methyl]cyclopropaneaceticAcidSodiuMSalt;

MontelukastSoudiuM;

MONTELUKSTSODIUM;

MONTELUKASTSODIUM;

MK-476,Singulair

Specification:

ITEMS	SPECIFICATION
CAS	151767-02-1
MF	C35H37ClNNaO3S
MW	610.18
Melting point	115 °C
Color	white to tan
Solubility	DMSO: ≥8mg/mL at 60℃
Form	Powder
Storage condition	2-8°C

Pharmacological effects:

Cysteinyl leukotrienes (LTC4, LTD4, LTE4) are eicosanoids with powerful inflammatory effects released by a variety of cells including mast cells and eosinophils. These important pre-asthmatic inflammatory mediators Binds to the cysteinyl leukotriene receptor (CysLT) found on human airways, resulting in a variety of airway responses, including bronchoconstriction, mucus secretion, increased vascular permeability, and eosinophil recruitment.

Usage: Suitable for alleviating symptoms caused by allergic rhinitis

Package and transportation :

Package: 10g,25g,50g,100g,250g